Ensayo clínico

REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness

NCT: NCT07792252 · NOT_YET_RECRUITING

ID NCTNCT07792252

EstadoNOT_YET_RECRUITING

SponsorYale University (OTHER)

First posted2026-08-28

Last updated2026-09-09

Resumen breve

Rejoyn is a Prescription Digital Therapeutic (PDT) for adults with Major Depressive Disorder (MDD). This study aims to evaluate the feasibility, engagement, and clinical context of integrating Rejoyn into standard interventional workflows at the Yale New Haven Hospital Interventional Psychiatry Service (IPS). This is a non-significant risk, observational real-world evidence (RWE) study.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.